Literature DB >> 27234679

Can we guarantee less nephrotoxicity when vancomycin is administered by continuous infusion?

Daniel Echeverría-Esnal1, Mónica Marín-Casino2, Alexandra Retamero1, Santiago Grau3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27234679     DOI： 10.1016/j.ijantimicag.2016.04.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  2 in total

1.  A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.

Authors:  Natalie A Finch; Evan J Zasowski; Kyle P Murray; Ryan P Mynatt; Jing J Zhao; Raymond Yost; Jason M Pogue; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

Review 2.  Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.

Authors:  Ali Hassoun; Peter K Linden; Bruce Friedman
Journal:  Crit Care       Date:  2017-08-14       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.